Icon

ELLENCE (nda050778)- (50MG/25ML (2MG/ML),200MG/100ML (2MG/ML))

EPIRUBICIN HYDROCHLORIDE PFIZER INC
50MG/25ML (2MG/ML),200MG/100ML (2MG/ML)
No No
2016-Jan-29 Expired
None None
None No
ELLENCE is an anthracycline topoisomerase inhibitor indicated as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer.
6 0 1
Total Other Developers 1
Drugs with Suitability No
50MG/25ML (2MG/ML) ** ** - - -
200MG/100ML (2MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ********** **** ********* *********** ************ **, **********, ***** ****** *****, ******* (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.